Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 03, 2026 04:41 ET | Source: Research and Markets

Global CRISPR-Based Drug Development Platforms Market to Reach USD 0.79 Billion by 2031: Precision Medicine and Gene Therapy Drive Growth

Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Crispr-Based Drug Development Platforms Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. ...
June 29, 2026 08:00 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

BERKELEY, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...
June 22, 2026 07:00 ET | Source: Endure Biotherapeutics, Inc.

Endure Biotherapeutics Receives NSF SBIR Phase I Grant for Phenylketonuria (PKU) Program and Reports Pig Study validates Engineered Native Bacteria platform technology

San Diego, June 22, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics Receives NSF SBIR Phase I Grant for Phenylketonuria (PKU) Program and Reports Pig Study validates...
June 15, 2026 07:05 ET | Source: Kraig Biocraft Laboratories

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

Kraig Labs (OTCQB: KBLB) CEO featured in an extensive interview with Pulse 2.0, where he discussed the Company's technological leadership, commercial produ
June 11, 2026 08:01 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026

-- Single dose of vispa-cel produced durable responses in 2L LBCL patients: 82% ORR, 67% CR rate, and 17.1-month mPFS -- -- Generally well-tolerated safety profile continues to support outpatient...
June 11, 2026 08:00 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case...
June 09, 2026 07:05 ET | Source: Kraig Biocraft Laboratories

Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle

Kraig Labs (OTCQB: KBLB) completed its largest production cycle in the Company's history, producing nearly 2.5 metric tons of spider silk cocoons
June 03, 2026 04:30 ET | Source: Custom Market Insights

[Latest] Global CRISPR-based Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, June 03, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “CRISPR-based Gene Editing Market Size, Trends and Insights By Product (Kits and...
May 26, 2026 07:35 ET | Source: Kraig Biocraft Laboratories

Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations

Kraig Labs (OTCQB: KBLB) spider silk cocoon collection, for its current production cycle, show early production yields exceeding targets by 20%.
May 21, 2026 13:30 ET | Source: Custom Market Insights

[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 21, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Genome Editing Market Size, Trends and Insights By Technology (CRISPR)/Cas9,...